Abstract # 2683 Radio-Immunotherapy (RIT): Long-term Follow-up Results with I-131 Labeled Antibody in 52 Patients with Non-Hodgkins Lymphoma (NHL) Refractory to Chemotherapy and Rituxan

Presenter: Colenda, Joseph

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

J. B. Colenda1, R. Mark1,2, P. Anderson1, T. Neumann1, M. Nair1, R. Akins1, D. Quick1, 1Joe Arrington Cancer Center, Lubbock, TX, 2Texas Tech University, Lubbock, TX

Author Disclosure:
J.B. Colenda, None;R. Mark, None;P. Anderson, None;T. Neumann, None;M. Nair, None;R. Akins, None;D. Quick, None.

E-mail a friend about this abstract:
Enter email address: